Use of the JAK Inhibitor Ruxolitinib in the Treatment of Hemophagocytic Lymphohistiocytosis

by Camille Keenan, Kim E. Nichols, Sabrin Albeituni
Published 2021-02-01

The Immunology of Macrophage Activation Syndrome

by Courtney B. Crayne, Sabrin Albeituni, Kim E. Nichols, Randy Q. Cron
Published 2019-02-01

Ruxolitinib, a JAK1/2 Inhibitor, Ameliorates Cytokine Storm in Experimental Models of Hyperinflammation Syndrome

by Eduardo Huarte, Michael T. Peel, Katherine Verbist, Brittany L. Fay, Rachel Bassett, Sabrin Albeituni, Kim E. Nichols, Paul A. Smith
Published 2021-04-01

Actively Targeted Nanodelivery of Echinomycin Induces Autophagy-Mediated Death in Chemoresistant Pancreatic Cancer In Vivo

by Alexandra Thomas, Abhilash Samykutty, Jorge G. Gomez-Gutierrez, Wenyuan Yin, Michael E. Egger, Molly McNally, Phillip Chuong, William M. MacCuaig, Sabrin Albeituni, Matthew Zeiderman, Min Li, Barish H. Edil, William E. Grizzle, Kelly M. McMasters, Lacey R. McNally
Published 2020-08-01